Natural constituents of St. John's Wort inhibit the proteolytic activity of human thrombin

• Published in: International journal of biological macromolecules 2019-08, Vol.134, p.622-630
• Main Authors: Wei, Ling-Hua, Chen, Tian-Ran, Fang, Hong-Bo, Jin, Qiang, Zhang, Shui-Jun, Hou, Jie, Yu, Yang, Dou, Tong-Yi, Cao, Yun-Feng, Guo, Wen-Zhi, Ge, Guang-Bo
• Format: Article
• Language: English
• Subjects: Dose-Response Relationship, Drug; Fibrinolytic Agents - chemistry; Fibrinolytic Agents - pharmacology; Hypericin; Hypericum - chemistry; Inhibitory effects; Kinetics; Molecular Docking Simulation; Molecular Dynamics Simulation; Molecular Structure; Perylene - analogs & derivatives; Perylene - chemistry; Perylene - pharmacology; Plant Extracts - chemistry; Plant Extracts - pharmacology; Proteolysis; Proteolytic activity; St. John's wort; Structure-Activity Relationship; Thrombin
• ISSN: 0141-8130; 1879-0003
• DOI: 10.1016/j.ijbiomac.2019.04.181

Thrombin, a multifunctional serine protease responsible for the proteolytic hydrolysis of soluble fibrinogen, plays a pivotal role in the blood coagulation cascade. Currently, thrombin inhibitor therapy has been recognized as an effective therapeutic strategy for the prevention and treatment of thrombotic diseases. In this study, the inhibitory effects of natural constituents in St. John's Wort against human thrombin are carefully investigated by a fluorescence-based biochemical assay. The results clearly demonstrate that most of naphthodianthrones, flavonoids and biflavones exhibit strong to moderate inhibition on human thrombin. Among all tested compounds, hypericin shows the most potent inhibitory capability against thrombin, with the IC50 value of 3.00 μM. Further investigation on inhibition kinetics demonstrates that hypericin is a potent and reversible inhibitor against thrombin-mediated Z-GGRAMC acetate hydrolysis, with the Ki value of 2.58 μM. Inhibition kinetic analyses demonstrate that hypericin inhibits thrombin-mediated Z-GGRAMC acetate hydrolysis in a mixed manner, which agrees well with the results from docking simulations that hypericin can bind on both catalytic cavity and anion binding exosites. All these findings suggest that hypericin is a natural thrombin inhibitor with a unique dianthrone skeleton, which can be used as a good candidate to develop novel thrombin inhibitors with improved properties.